Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids-Reference-Cited by-同舟云学术

Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids

Published:2022-08-03 Issue:7-8 Volume:18 Page:441-457
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Evangelisti Giulio¹^ORCID,Barra Fabio¹²³^ORCID,Perrone Umberto¹,Di Donato Nadine²,Bogliolo Stefano⁴,Ceccaroni Marcello³,Ferrero Simone¹

Affiliation:

1. Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

2. Southern Endometriosis Centre, Queen Alexandra Hospital, Portsmouth, UK

3. Department of Obstetrics and Gynecology, Gynecology Oncology and Minimally-Invasive Pelvic Surgery, International School of Surgical Anatomy (ISSA), IRCCS Ospedale Sacro Cuore - Don Calabria, Negrar (Verona), Italy

4. Unit of Obstetrics and Gynecology, P.O. 'Ospedale del Tigullio”-ASL4, Metropolitan Area of Genoa, Genoa, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2022.2113381

Reference187 articles.

1. Uterine fibroid management: from the present to the future

2. Tissue Stem Cells and Uterine Physiology and Pathology

3. Recent Advances in Uterine Fibroid Etiology

4. Uterine Fibroids and Infertility

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies;Expert Opinion on Therapeutic Targets;2024-08-02

2. Experimental and new investigational drugs for the treatment of uterine fibroids;Expert Opinion on Investigational Drugs;2024-04-17

3. The Effect of a Myomectomy on Myoma-related Symptoms and Quality of Life: A Retrospective Cohort Study;Journal of Minimally Invasive Gynecology;2023-11

4. A review of phase II and III drugs for the treatment and management of endometriosis;Expert Opinion on Emerging Drugs;2023-10-02

5. Terapias emergentes en el tratamiento médico de los miomas uterinos;Medicina Clínica;2023-10